News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hopson Ricky
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Hopson Ricky (Pres. Clinical Dev Supply Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 789 shares
@ $0
Sold 276 shares
@ $44.56, valued at
$12.3k
|
|
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| Hopson Ricky (Pres. Clinical Dev Supply Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 195 shares
@ $47.86, valued at
$9.3k
Granted 4,790 shares
@ $0
Granted 10,669 options to buy
@ $46.51, valued at
$496.2k
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/25/2023 |
4
| Hopson Ricky (Pres. Clinical Dev Supply Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 643 shares
@ $49.36, valued at
$31.7k
|
|
| 09/02/2022 |
4
| Hopson Ricky (Pres. Clinical Dev Supply Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 2,216 shares
@ $89.59, valued at
$198.5k
|
|
| 08/26/2022 |
4
| Hopson Ricky (Pres. Clinical Dev Supply Div) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 3,733 shares
@ $0
Sold 1,517 shares
@ $103.04, valued at
$156.3k
|
|
| 07/28/2022 |
4
| Hopson Ricky (Pres, Clinical Dev & Supply) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 312 shares
@ $106.9, valued at
$33.4k
Granted 651 shares
@ $0
Sold 591 shares
@ $107.67, valued at
$63.6k
Granted 2,828 options to buy
@ $107.63, valued at
$304.4k
|
|
| 02/01/2022 |
4
| Hopson Ricky (VP, Chief Accounting Officer) has filed a Form 4 on Catalent, Inc.|
Txns:
| Sold 2,325 shares
@ $103.39, valued at
$240.4k
|
|
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|